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e neonatal lupus syndrome consists of transient T cutaneous lupus lesions or permanent congenital complete heart block (or hepatic fibrosis), or 
both, occurring in a small percentage of infants born 
to mothers with systemic lupus erythematosus (SLE). 
The prevalence of connective tissue disease in moth- 
ers of babies with congenital complete heart block 
ranges from 33 to 64%. 12 Half of these women are 
symptomatic; the other half have only serologic evi- 
dence of connective tissue disease.3 In symptomatic 
mothers, SLE is the usual underlying disorder, but Sjo- 
gren syndrome, rheumatoid arthritis and undifferentiat- 
ed connective tissue disease have also been found.2*4*5 
In 1 study, the relation ‘between maternal high-titer 
antibody and congenital complete heart block suggest- 
ed a possible dose-response effect.6 However, the elec- 
trocardiograms of all the infants were not reported. 
Support for a dose-response relation would be in- 
creased, if more subtle conduction disturbances were 
detected by the electrocardiogram. This study exam- 
ines the frequency of conduction abnormalities in off- 
spring of mothers with SLE by identifying mothers 
with SLE rather than by identifying affected infants. 
Our hypothesis is that offspring of mothers with SLE 
would have a spectrum of conduction disturbances on 
the resting electrocardiogram ranging from first-degree 
atrioventricular block to the already recognized con- 
genital complete heart block. 
METHODS 
In 1982 and again in 1988, women with SLE (1982 
American Rheumatism Association revised criteria for 
SLE) followed in the Rheumatology Clinic at the Uni- 
versity of Michigan were asked at the time of their reg- 
ularly scheduled appointment if they had ever been 
pregnant. For each cohort (1982 [n = 321 and 1988 
[n = 21]), women with children were later contacted 
by telephone and asked to participate in the study. 
Thirty-two of 42 mothers contacted in 1982 and 21 of 
22 in 1988 agreed to participate in the study. In all, 84 
of 92 living offspring of 53 women were evaluated. 
Except for 3 siblings who had elecnocardiograms 
obtained at a local hospital, electrocardiograms were 
recorded on a Cambridge VS-550 electrocardiograph- 
ic recorder (frequency response, direct current to 100 
Hz) with a heat writer on paper moving at 50 mm/s. 
Consent forms and questionnaires pertaining to the 
mother’s and child’s medical history were completed for 
each offspring. Anti-SSA/Ro and Anti-SSb/La anti- 
body status was available from 25 mothers (18 from 
1988, and 7 from 1982). The study protocol, written 
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consent forms and questionnaires for both cohorts were children have been published, are widely accepted and 
similar and were approved by the institutional review are constant over time, a contemporary control group 
board of the University of Michigan, was not necessary. We used standards published in 1980 
Electrocardiographic intervals (Table I) (heart rate, by Davignon et al7 that were derived from data in a pop- 
and PR, QRS and QT intervals) were measured inde- ulation of 2,141 children (age range 0 to 16 years) divid- 
pendently by 2 investigators using a ruler calibrated to ed into 12 age groups. Age-dependent PR intervals and 
0.5 mm. Because electrocardiographic standards for QRS duration percentiles, as well as distributions of 
TABLE I Maternal Antibody Status and Offspring Electrocardiographic Data F i Electrocardiographic Intervals 
, 
Age HR PR QRS QTNC 
Mother Ro-Ab La-Ab Offspring (year) (beats/min) (ms) (ms) (ms) 
1 W Neg 1A 14 91 130 70 340 
1B 11 92 160 80 320 
2 Pos Pos 2 17 85 120 80 320 
3 Neg Neg 3 2 115 110 80 280 
4 Nag Neg 4 3 101 160 80 320* 
5 Pos Pos 5 16 107 120 60 300 
6 Pos Neg 6 8 81 120 70 350 
7 Pos Neg 7 24 79 140 80 340 
8 NA NA 8 6 107 100 60 320 
9 NA NA QA 12 64 160 80 340 
9B 15 58 160 100 400 
9c 14 58 90 100 440t 
10 ki! Neg 10A 6 100 170 100 300$ 
10B 9 65 130 60 340 
IOC 12 75 150 70 360 
11 Neg Neg 11 6 97 120 80 320 
12 N% Neg 12 6 64 120 80 360 
13 Pos Neg 13 3 143 130 60 260 
14 Pos Pos 14 15 65 140 80 360 
15 Pos Neg 15A 13 71 160 40 330 
158 6 95 150 60 320 
16 Neg Neg 16 2 140 120 50 260 
17 Neg Neg 17 0.5 136 170 50 300$ 
18 NA NA 18A 28 98 160 70 330* 
188 36 85 180 80 330* 
18C 39 88 160 60 360 
19 Neg Neg 19 13 79 140 80 350 
20 Pns Neg 20 6 89 110 50 300 
21 Pos Pos 21A 10 100 120 80 320 
228 0.3 118 80 50 3001 
22 NA NA 22A 13 77 160 70 320 
NA NA 228 15 95 140 80 340 
23 NA NA 23 0.11 165 110 40 220 
24 kz Neg 24 0.13 200 80 40 220 
25 NA NA 25A 13 83 140 60 360 
258 20 75 140 100 370 
26 NA NA 26 4 75 120 60 320 
27 NA NA 27 3 100 140 80 320 
28 NA NA 28~ 4 95 140 70 300 
NA NA 288 12 82 120 70 370 
NA NA 28C 17 67 140 60 360 
NA NA 28D 21 78 150 60 340 
29 Neg W 29A 15 70 150 90 380 
Neg W 298 12 67 130 80 400 
W Neg 29c 9 65 160 80 380 
30 NA NA 30A 10 75 120 60 320 
NA NA 308 5 80 120 60 320 
31 NA NA 31A 11 60 120 70 380 
32 Neg Neg 32A 15 73 160 90 360 
Neg Neg 328 13 69 180 80 370$ 
33 NA NA 33A 11 105 130 60 300 
NA NA 338 10 67 140 60 370 
NA NA 33c 9 107 120 70 300 
*First-degree heart block for age or heart rate; tatrioventrcular dissociation with functional rhythm; thnt-degree 
atrioventricular block far both age and heart rate; gshort PR interval with no 8 wave, suggesting enhanced atrlovantricular 
:onduction. 
HR = heart rate; La-Ab = antl-La antibody; NA = not available: Neg = maternal antIbody not detectable; Pas = maternal 
3ntibody present; PR = PR interval; Ro-Ab = anti-Ro antibody. 
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TABLE I (Cant’d) 
Electrocardiographic 
Intervals 
Mother Ro-Ab La-Ab Offspring 
4% HR PR QRS QTNC 






















































































34A 22 60 160 80 360 
348 26 75 180 60 360* 
34c 31 49 160 100 380 
34D 28 77 140 80 400 
35A 14 75 140 60 360 
358 7 80 120 80 360 
36 24 74 160 80 400 
36A 15 75 140 100 370 
368 14 75 160 100 330 
38 7 72 120 60 300 
39A 33 63 160 80 360 
398 30 72 140 80 360 
39c 24 75 140 90 320 
40 7 136 150 80 260 
41A 20 86 150 70 330 
418 23 63 160 60 340 
41c 25 88 140 50 320 
42 31 75 160 80 370 
43A 5 88 140 80 340 
43B 10 88 120 60 340 
44 10 100 140 60 320 
45 42 75 100 60 370 
46A 11 70 120 80 380 
468 12 68 120 60 400 
47 14 96 140 80 360 
48 32 70 150 60 340 
49 28 77 140 70 360 
50 12 114 160 60 310 
51A 28 68 120 60 360 
518 25 60 180 70 440 
52A 14 75 130 90 320 
52B 17 53 160 90 380 
53 20 100 140 70 320 
*First-degree heart block for age or heart rate; tatrioventricular dissociation with junctional rhythm: $first-degree 
atrioventricular block for both age and heart rate: §short PR interval with no 6 wave, suggesting enhanced atrloventrlcular 
conduction. 
HR = heart rate; La-Ab = anti-la antibody; NA = not available: Neg = maternal antibody not detectable; Pos = maternal 
antibody present; PR = PR interval; Ro-Ab = anti-R0 antibody. 
these values, from that study were used as the norma- RESULTS 
tive values in the present study. However, because of the 
wide range of normal PR intervals at different heart rates 
and ages (Figures 3 and 4 from Davignon et al),7 each 
PR interval of the subjects in our study was assigned a 
rank order of 1 to 8 corresponding, in order, to a rank 
value <2nd percentile (rank value = l), between the 2nd 
and 5th, the 5th and 25th, the 25th and 5Oth, the 50th 
and 75th the 75th and 95th, and the 95th and 98th per- 
centiles, and linally, >98th percentile (rank value = 8). 
The following 3 analyses were then perform& (1) com- 
parison of the 1982 and 1988 data to determine if the 
cohorts differed, (2) comparison of all data to examine 
the effect of onset (before and during vs after pregnan- 
cy), as well as other variables; and (3) repetition of anal- 
ysis 2 using only data from the eldest child to eliminate 
any intrafamily effects. Tests used to perform these anal- 
yses included l-way analysis of variance model, Mann- 
Whitney nonparametric test, &i-square test of indepen- 
dence, and analysis of co-variance and log-linear mod- 
els. Differences were considered signiticant if the p 
value was 10.05. 
In this group of 53 women with SLE, serologic re- 
sults were known for 25 (Table I). A woman was con- 
sidered as having anti-SSA/Ro antibody if the antibody 
was found at any time. The rationale for this assump- 
tion is based on the reported occurrence of anti-SSA/Ro 
antibody before the onset of symptoms of SLE3 and 
because this antibody tends to remain present over pro- 
longed periods of time.8 Of these 25 women, most 
(76%) were antinuclear antibody positive; 50% were 
anti-SSA/Ro antibody positive, and 56% were anti- 
SSB/La antibody positive. No mother had a child with 
congenital complete heart block. 
The mean age of the offspring studied was 14.5 + 
9.5 years. One-way analysis showed that the 1982 co- 
hort was older (p = 0.05) and, as would thus be expect- 
ed, had a slower heart rate (p = 0.04) than did the 1988 
cohort. However, the electrocardiographic intervals did 
not differ significantly between the 2 groups. SLE was 
diagnosed before or during pregnancy in 28 cases and 
after pregnancy in the remaining 58. During 7 pregnan- 
cies, the mothers were treated with prednisone. 
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Analysis of electrocardiographic data (Table I) 
showed sinus rhythm in 85 of 86 offspring. A 16year- 
old male offspring had both intermittent atrioventricular 
dissociation and normal sinus rhythm, but normal atri- 
oventricular conduction during sinus rhythm. Serologic 
data were not available from this subject’s mother. One 
20-year-old female offspring had right-axis deviation. 
The PR interval was ~95th percentile for age (i.e., nor- 
mal) in 82 of 86 offspring and ~95th percentile for heart 
rate in 81. Three children had a PR interval >95th per- 
centile (i.e., t&t-degree heart block) for both age and 
heart rate: A B-month-old male had a PR interval of 0.17 
seconds at a heart rate of 136 beats/mm a 6-year-old 
male had a PR interval of 0.17 second at a heart rate of 
100 beats/min, and a 13-year-old male had a PR of 0.18 
second at a heart rate of 69 beats/min. Although 2 of 
the mothers of these 3 subjects developed SLE before 
or during the pregnancy, all 3 mothers’ serum was 
devoid of anti-SSA/Ro and anti-SSB/La antibody. The 
PR interval of the other 6 subjects with lust-degree heart 
block for age or heart rate (i.e., 295th percentile) was 
10.18 second. However, all offspring had intact atri- 
oventricular conduction, and no other isolated electro- 
cardiographic abnormalities were found. 
In contrast to the individual data, grouped data sug- 
gested subtle effects of maternal SLE on atrioventricu- 
lar conduction in offspring. Using the aforementioned 
rank assignment of PR intervals in relation to heart rate 
and age (and heart rate in relation to age), 2 differences 
were observed. First, heart rate adjusted for age was sig- 
nificantly (p = 0.003) higher in offspring whose moth- 
ers had the onset of SLE before or during pregnancy 
than in the normal population’; this difference was not 
present for children whose mothers developed SLE after 
pregnancy. Second, PR interval adjusted for heart rate 
(i.e., rank score indicating a difference in percentile 
level) was significantly (p = 0.0001) longer (i.e., score 
was greater) in offspring whose mothers developed SLE 
before or during pregnancy than in the normal popula- 
tion.’ This difference was not present for subjects whose 
mothers developed SLE after pregnancy. These relations 
remained when only the eldest child was included in the 
analysis, supporting the likelihood of a difference relat- 
ed to SLE effects rather than to intrafamily effects. How- 
ever, the data were insufficient to distinguish between the 
effects of age and onset of SLE (before and during vs 
after pregnancy) on PR interval. The analysis examining 
an antibody effect on PR interval produced no signifi- 
cant results, perhaps owing to a small number of women 
in whom antibody status was known. 
DISCUSSION 
In these 2 cohorts comprising 86 offspring of 53 
mothers with SLE, we detected no isolated, significant, 
electrocardiographic abnormalities, even in children 
whose mothers were anti-SSA/Ro antibody positive. 
Fist-degree atrioventricular block was detected in 3 off- 
spring; however, the 3 respective mothers were antibody 
negative during pregnancy, suggesting that in these cases 
the minor conduction abnormalities were probably unre- 
lated to neonatal SLE. Similarly, the finding of an inter- 
mittent escape junctional rhythm in 1 adolescent off- 
spring, as well as the right-axis deviation in another, 
probably represents a normal variant. However, the 
grouped data suggest that a subclinical effect of mater- 
nal SLE may be affecting the fetus and may contribute 
to a subtle delay in atrioventricular conduction in the 
fully developed infant or child. 
Mechmwlti-neon&tll~otyt- 
8~8: Neonatal SLE syndrome is mediated by the trans- 
placental passage (after the 12th to 16th week of gesta- 
tion) of maternal immunoglobulin G antibodies to the 
fetus of a woman with SLE, followed by an immunolog- 
ically-based intlammatory reaction (and/or deposition) of 
these antibodies with antigens of the fetal skin and heart, 
or botl-~.~,~~~,~--i~ Anti-SSA/Ro and anti-SSB/La antibod- 
ies to soluble tissue ribonucleoprotein antigens found in 
the cytoplasm or nucleus of human cells, or both,‘O have 
been proposed as the etiologic agents of congenital com- 
plete heart block. t ’ Demonstration of immunofluores- 
cence from antibody deposition in cardiac tissue pro- 
vides evidence that place&thy transmitted immunoglob- 
ulin G antibodies may act directly on the heart, 
producing deposition at the atrioventricular node, central 
fibrous body and fibrous annulu~.~~*~ Furthermore, 
Alexander et al*O have demonstrated an antibody (anti- 
SSA/Ro and anti-SSB/La)-mediated inhibition of neona- 
tal rabbit cardiac repolarization, indicating a direct effect 
on the electrophysiologic properties of developing 
excitable tissue. All these observations are compatible 
with a dose-response effect of maternal antibodies on 
immature atrioventricular conduction tissue. 
Risk to fetus: In a retrospective study of offspring 
of women with SLE, Ramsey-Goldman et al6 described 
16 infants with congenital complete heart block in 96 
pregnancies of women who had anti-SSA/Ro antibody. 
In contrast, only 1 infant in 235 pregnancies of women 
with SLE but without anti-SSA/Ro antibody had neo- 
natal SLE. In that study, the overall risk of a woman 
with SLE having an infant with congenital complete 
heart block was estimated to be 1:60 (when corrected 
for referral bias), but the risk was considerably greater 
(1:20) if anti-SSA/Ro antibody was present. Buyon et 
al*l have described maternal antibodies from the moth- 
ers of neonatal SLE infants to specific peptides of the 
ribonuclear SSA/Ro complex, as well as to the SSB/La 
particle; both of these peptides are abundant in fetal car- 
diac tissues. The presence of antibodies to these specific 
peptides increases the risk ratio of a mother with SLE 
giving birth to an infant with neonatal lupus by a factor 
of 35. 
Clinical impliii The incidence, reduced mor- 
bidity and improved survival of women of childbearing 
age affected by SLE renders pregnancy in these cases 
an important clinical problem. This study was retro- 
spective. Thus, transient conduction disturbances in the 
neonatal period may have been overlooked. However, 
the study underscores the strong possibility of subclini- 
cal alterations in atrioventricular conduction in some fe- 
tuses exposed to a maternal SLE environment, and thus 
supports a dose-response relation between atrioventricu- 
lar conduction in the fetus and infant and maternal SLE 
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antibodies. However, because of bradycardia noted in 
the newborn at birth, congenital high-grade or complete 
heart block is usually recognized and confirmed by elec- 
trocardiography. Thus, if the heart rate of a fetus or 
newborn whose mother has SLE is normal, neither early 
obstetric intervention nor routine postnatal electrocar- 
diograms are necessary. 
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